Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
2.900
+0.120 (4.32%)
At close: Mar 9, 2026, 4:00 PM EDT
2.960
+0.060 (2.07%)
After-hours: Mar 9, 2026, 6:13 PM EDT
Eledon Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 230 | 246 | 44 | 31 | 63 | 233 | |
| Market Cap Growth | -10.21% | 465.07% | 38.87% | -50.29% | -72.98% | 3004.22% | |
| Enterprise Value | 137 | 168 | -16 | -34 | -31 | 119 | |
| Last Close Price | 2.90 | 4.12 | 1.80 | 2.28 | 4.41 | 15.40 | |
| PB Ratio | 1.91 | 2.08 | 6.04 | 0.37 | 0.39 | 1.23 | |
| P/TBV Ratio | 3.92 | 2.87 | - | 0.61 | 0.76 | 2.13 | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.05 | 0.01 | 0.01 | 0.00 | |
| Net Debt / Equity Ratio | -1.02 | -1.18 | -7.04 | -0.66 | -0.51 | -0.60 | |
| Net Debt / EBITDA Ratio | - | - | - | - | 2.28 | 8.59 | |
| Net Debt / FCF Ratio | 1.38 | 2.95 | 1.28 | 1.96 | 2.91 | 7.50 | |
| Quick Ratio | 6.59 | 12.11 | 13.12 | 8.71 | 19.28 | 46.04 | |
| Current Ratio | 6.74 | 12.42 | 14.41 | 9.19 | 20.07 | 46.57 | |
| Return on Equity (ROE) | -95.49% | -57.73% | -255.03% | -70.89% | -19.46% | -22.80% | |
| Return on Assets (ROA) | -44.22% | -33.11% | -29.56% | -18.88% | -12.53% | -7.98% | |
| Return on Capital Employed (ROCE) | -74.80% | -42.60% | -50.50% | -46.10% | -22.20% | -6.80% | |
| Earnings Yield | -35.92% | -14.70% | -267.55% | -280.45% | -54.69% | -9.77% | |
| FCF Yield | -29.22% | -19.21% | -90.75% | -90.62% | -45.83% | -6.52% | |
| Buyback Yield / Dilution | -94.74% | -97.18% | -72.34% | 3.61% | -921.03% | -121.42% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.